DNTH•benzinga•
HC Wainwright & Co. Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $40
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga